(HCC) Warrior Met Coal - Ratings and Ratios
Hard-Coking Coal, Natural Gas
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.35% |
| Yield on Cost 5y | 1.56% |
| Yield CAGR 5y | 12.47% |
| Payout Consistency | 65.2% |
| Payout Ratio | 40.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 47.5% |
| Value at Risk 5%th | 70.1% |
| Relative Tail Risk | -10.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.14 |
| Alpha | 53.50 |
| CAGR/Max DD | 0.91 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.355 |
| Beta | 0.650 |
| Beta Downside | 0.791 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.53% |
| Mean DD | 14.96% |
| Median DD | 12.97% |
Description: HCC Warrior Met Coal November 09, 2025
Warrior Met Coal, Inc. (NYSE:HCC) produces and exports hard-coking coal used in steelmaking, primarily serving metal manufacturers in Europe, South America, and Asia. Its operations are based on underground mines in Alabama, and the company also monetizes natural gas recovered as a by-product of coal extraction. Incorporated in 2015, Warrior’s headquarters are in Brookwood, Alabama.
Key operational metrics as of the latest 2023 filing show roughly 7.5 million short tons of coking coal sold, generating an average realized price of about $140 per short ton, and a net debt-to-EBITDA ratio near 2.2×, indicating moderate leverage. The firm’s revenue is highly sensitive to global steel demand and coking-coal price cycles, which are driven by macro-economic growth in emerging markets and the ongoing transition to higher-efficiency steelmaking technologies such as electric-arc furnaces.
If you want a data-rich, side-by-side comparison of Warrior Met Coal’s valuation and forward estimates, a quick look at its profile on ValueRay can provide the additional context needed for a deeper dive.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (35.2m TTM) > 0 and > 6% of Revenue (6% = 73.4m TTM) |
| FCFTA -0.06 (>2.0%) and ΔFCFTA -8.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 49.70% (prev 50.57%; Δ -0.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 207.4m > Net Income 35.2m (YES >=105%, WARN >=100%) |
| Net Debt (-99.7m) to EBITDA (150.7m) ratio: -0.66 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (52.6m) change vs 12m ago 0.49% (target <= -2.0% for YES) |
| Gross Margin 29.64% (prev 28.38%; Δ 1.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 46.47% (prev 61.68%; Δ -15.21pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.01 (EBITDA TTM 150.7m / Interest Expense TTM 8.12m) >= 6 (WARN >= 3) |
Altman Z'' 7.30
| (A) 0.23 = (Total Current Assets 802.0m - Total Current Liabilities 194.3m) / Total Assets 2.68b |
| (B) 0.70 = Retained Earnings (Balance) 1.87b / Total Assets 2.68b |
| (C) 0.01 = EBIT TTM 24.4m / Avg Total Assets 2.63b |
| (D) 3.32 = Book Value of Equity 1.87b / Total Liabilities 564.8m |
| Total Rating: 7.30 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 29.62
| 1. Piotroski 4.0pt |
| 2. FCF Yield -3.68% |
| 3. FCF Margin -13.87% |
| 4. Debt/Equity 0.11 |
| 5. Debt/Ebitda -0.66 |
| 6. ROIC - WACC (= -6.87)% |
| 7. RoE 1.68% |
| 8. Rev. Trend -60.96% |
| 9. EPS Trend -86.14% |
What is the price of HCC shares?
Over the past week, the price has changed by +2.44%, over one month by +14.90%, over three months by +42.22% and over the past year by +71.02%.
Is HCC a buy, sell or hold?
- Strong Buy: 3
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HCC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 89.2 | -1.8% |
| Analysts Target Price | 89.2 | -1.8% |
| ValueRay Target Price | 127.9 | 40.8% |
HCC Fundamental Data Overview January 04, 2026
P/E Trailing = 135.6818
P/E Forward = 14.245
P/S = 3.8451
P/B = 2.1885
Beta = 0.706
Revenue TTM = 1.22b USD
EBIT TTM = 24.4m USD
EBITDA TTM = 150.7m USD
Long Term Debt = 154.1m USD (from longTermDebt, last quarter)
Short Term Debt = 25.2m USD (from shortTermDebt, last quarter)
Debt = 236.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -99.7m USD (from netDebt column, last quarter)
Enterprise Value = 4.61b USD (4.71b + Debt 236.6m - CCE 336.3m)
Interest Coverage Ratio = 3.01 (Ebit TTM 24.4m / Interest Expense TTM 8.12m)
FCF Yield = -3.68% (FCF TTM -169.6m / Enterprise Value 4.61b)
FCF Margin = -13.87% (FCF TTM -169.6m / Revenue TTM 1.22b)
Net Margin = 2.88% (Net Income TTM 35.2m / Revenue TTM 1.22b)
Gross Margin = 29.64% ((Revenue TTM 1.22b - Cost of Revenue TTM 860.3m) / Revenue TTM)
Gross Margin QoQ = 11.35% (prev 6.60%)
Tobins Q-Ratio = 1.72 (Enterprise Value 4.61b / Total Assets 2.68b)
Interest Expense / Debt = 0.98% (Interest Expense 2.31m / Debt 236.6m)
Taxrate = -60.15% (out of range, set to none) (-13.7m / 22.9m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 4.13 (Total Current Assets 802.0m / Total Current Liabilities 194.3m)
Debt / Equity = 0.11 (Debt 236.6m / totalStockholderEquity, last quarter 2.12b)
Debt / EBITDA = -0.66 (Net Debt -99.7m / EBITDA 150.7m)
Debt / FCF = 0.59 (negative FCF - burning cash) (Net Debt -99.7m / FCF TTM -169.6m)
Total Stockholder Equity = 2.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.31% (Net Income 35.2m / Total Assets 2.68b)
RoE = 1.68% (Net Income TTM 35.2m / Total Stockholder Equity 2.09b)
RoCE = 1.09% (EBIT 24.4m / Capital Employed (Equity 2.09b + L.T.Debt 154.1m))
RoIC = 1.13% (EBIT 24.4m / (Assets 2.68b - Curr.Liab 194.3m - Cash 336.3m))
WACC = 8.01% (E(4.71b)/V(4.94b) * Re(8.41%) + (debt cost/tax rate unavailable))
Discount Rate = 8.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
Fair Price DCF = unknown (Cash Flow -169.6m)
EPS Correlation: -86.14 | EPS CAGR: -45.73% | SUE: -0.01 | # QB: 0
Revenue Correlation: -60.96 | Revenue CAGR: -6.12% | SUE: 1.12 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.40 | Chg30d=+0.350 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=7.26 | Chg30d=+0.728 | Revisions Net=+0 | Growth EPS=+446.0% | Growth Revenue=+44.1%
Additional Sources for HCC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle